Aldeyra Therapeutics (ALDX) Appoints Stephen Tulipano Chief Financial Officer
6/19/2014 8:50:01 AM
BURLINGTON, Mass., June 19, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free aldehydes, today announced that Stephen Tulipano has joined Aldeyra as its Chief Financial Officer, effective June 23, 2014. Mr. Tulipano will report directly to Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra.
Help employers find you! Check out all the jobs and post your resume.
comments powered by